$291.24
0.19% day before yesterday
NYSE, May 30, 10:12 pm CET
ISIN
US03073E1055
Symbol
COR

Cencora Stock price

$291.24
-1.43 0.49% 1M
+41.37 16.56% 6M
+66.56 29.62% YTD
+70.71 32.06% 1Y
+134.38 85.67% 3Y
+196.09 206.09% 5Y
+177.98 157.14% 10Y
NYSE, Closing price Fri, May 30 2025
+0.55 0.19%
ISIN
US03073E1055
Symbol
COR
Sector

Key metrics

Market capitalization $56.45b
Enterprise Value $62.33b
P/E (TTM) P/E ratio 33.59
EV/FCF (TTM) EV/FCF 17.43
EV/Sales (TTM) EV/Sales 0.20
P/S ratio (TTM) P/S ratio 0.18
P/B ratio (TTM) P/B ratio 55.72
Dividend yield 0.70%
Last dividend (FY24) $2.04
Revenue growth (TTM) Revenue growth 12.19%
Revenue (TTM) Revenue $310.23b
EBIT (operating result TTM) EBIT $3.19b
Free Cash Flow (TTM) Free Cash Flow $3.58b
Cash position $1.98b
EPS (TTM) EPS $8.67
P/E forward 21.88
P/S forward 0.18
EV/Sales forward 0.19
Short interest 5.37%
Show more

Is Cencora a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Cencora Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Cencora forecast:

11x Buy
61%
6x Hold
33%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Cencora forecast:

Buy
61%
Hold
33%
Sell
6%

Financial data from Cencora

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
310,232 310,232
12% 12%
100%
- Direct Costs 300,011 300,011
12% 12%
97%
10,221 10,221
9% 9%
3%
- Selling and Administrative Expenses 5,946 5,946
8% 8%
2%
- Research and Development Expense - -
-
-
4,275 4,275
9% 9%
1%
- Depreciation and Amortization 1,088 1,088
0% 0%
0%
EBIT (Operating Income) EBIT 3,187 3,187
13% 13%
1%
Net Profit 1,693 1,693
9% 9%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cencora directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cencora Stock News

Neutral
Business Wire
4 days ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1, 2025. “Ms. Ryerkerk's experience in complex, global supply chains will further strengthen the Board's expertise as we continue supporting the company's long-term growth. Her appointment reflects the Cencora Board'...
Positive
Seeking Alpha
16 days ago
Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment points to continued demand for the healthcare supplies and niche specialty drugs Cencora can distribute. Future share price targets point to significant potential upside over 3 years, justifying a buy despite the stock trading above average now.
Neutral
Seeking Alpha
25 days ago
Cencora, Inc. (NYSE:COR ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Bob Mauch - President & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Capital Lisa Gil...
More Cencora News

Company Profile

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Head office United States
CEO Robert Mauch
Employees 44,000
Founded 1947
Website www.cencora.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today